Carles Rafols Priu (Carles Rafols)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Cardiovascular Disease

Direct Oral Anticoagulants

Top Venues

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro Isidoro Pérez Cabeza, Jaime Masjuan Vallejo, Esther Recalde Del Vigo, José Manuel Vázquez Rodríguez, Román Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas-Ynsaurriaga, Carles Rafols Priu, Manuel Anguita Sánchez
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of comparative effectiveness research 12 (3) (2023)
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro Isidoro Pérez Cabeza, Jaime Masjuan Vallejo, Esther Recalde Del Vigo, José Manuel Vázquez Rodríguez, Román Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas-Ynsaurriaga, Carles Rafols Priu, Manuel Anguita Sánchez
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of comparative effectiveness research (2023)
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro Isidoro Pérez Cabeza, Jaime Masjuan Vallejo, Esther Recalde Del Vigo, José Manuel Vázquez Rodríguez, Román Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas-Ynsaurriaga, Carles Rafols Priu, Manuel Anguita Sánchez
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of comparative effectiveness research 12 (3) (2023)
Francisco Marín, Marcelo Sanmartín Fernández, Iñaki Lekuona, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosín Sales, Román Freixa-Pamias, Jaime Masjuan Vallejo, Alejandro Isidoro Pérez Cabeza, Vanessa Roldán Schilling, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Manuel Anguita Sánchez
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries. Journal of comparative effectiveness research 11 (16) (2022)
Marcelo Sanmartín Fernández, Francisco Marín, Carles Rafols Priu, Fernando Arribas-Ynsaurriaga, Vivencio Barrios, Juan Cosín Sales, Manuel Anguita Sánchez, null null
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study). Journal of comparative effectiveness research 10 (7) (2021)